论文部分内容阅读
目的探讨乳糖酸阿奇霉素治疗小儿支原体肺炎的临床效果。方法整取抽样我院2013年3月-2015年8月确诊的小儿支原体肺炎患儿108例,按随机数字表法分为2组,对照组54例,给予红霉素治疗,观察组54例,给予乳糖酸阿奇霉素治疗,治疗10-14d后,观察两组用药效果,并评价其用药安全性。结果观察组用药总有效率高于对照组(P<0.05);观察组用药不良反应发生率低于对照组(P<0.05)。结论对小儿支原体肺炎患儿采取乳糖酸阿奇霉素治疗的疗效显著,改善患儿临床症状,且用药安全性较好。
Objective To investigate the clinical effect of azithromycin lactobionate on mycoplasma pneumonia in children. Methods We collected 108 children with mycoplasma pneumonia who were diagnosed in our hospital from March 2013 to August 2015. They were divided into two groups according to the random number table method. The control group received 54 cases of erythromycin and the observation group of 54 cases , To give lactobionate azithromycin treatment, treatment 10-14d, the two groups observed the effect of medication, and evaluate the safety of medication. Results The total effective rate of the observation group was higher than that of the control group (P <0.05). The adverse reaction rate of the observation group was lower than that of the control group (P <0.05). Conclusion The treatment of children with mycoplasma pneumonia with azithromycin lactobionate treatment significantly improved the clinical symptoms of children, and drug safety better.